RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Caliway Biopharmaceuticals Co Stock

Caliway Biopharmaceuticals Co Equity 2024

Caliway Biopharmaceuticals Co Equity

1.16 B TWD

Ticker

6919.TWO

ISIN

TW0006919004

In 2024, Caliway Biopharmaceuticals Co's equity was 1.16 B TWD, a 80.6% increase from the 644.66 M TWD equity in the previous year.

Caliway Biopharmaceuticals Co Aktienanalyse

What does Caliway Biopharmaceuticals Co do?

Caliway Biopharmaceuticals Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Caliway Biopharmaceuticals Co's Equity

Caliway Biopharmaceuticals Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Caliway Biopharmaceuticals Co's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Caliway Biopharmaceuticals Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Caliway Biopharmaceuticals Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Caliway Biopharmaceuticals Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Caliway Biopharmaceuticals Co stock

What is the equity of Caliway Biopharmaceuticals Co this year?

Caliway Biopharmaceuticals Co has equity of 1.16 B TWD this year.

What was the equity of Caliway Biopharmaceuticals Co compared to the previous year?

The equity of Caliway Biopharmaceuticals Co has increased/decreased by 80.6% increased compared to the previous year.

What impact does a high equity have on investors of Caliway Biopharmaceuticals Co?

A high equity is advantageous for investors of Caliway Biopharmaceuticals Co as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Caliway Biopharmaceuticals Co?

A low equity can be a risk for investors of Caliway Biopharmaceuticals Co, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Caliway Biopharmaceuticals Co affect the company?

An increase in equity of Caliway Biopharmaceuticals Co can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Caliway Biopharmaceuticals Co affect the company?

A reduction in equity of Caliway Biopharmaceuticals Co can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Caliway Biopharmaceuticals Co?

Some factors that can affect the equity of Caliway Biopharmaceuticals Co include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Caliway Biopharmaceuticals Co so important for investors?

The equity of Caliway Biopharmaceuticals Co is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Caliway Biopharmaceuticals Co take to change the equity?

To change equity, Caliway Biopharmaceuticals Co can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Caliway Biopharmaceuticals Co pay?

Over the past 12 months, Caliway Biopharmaceuticals Co paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Caliway Biopharmaceuticals Co is expected to pay a dividend of 0 TWD.

What is the dividend yield of Caliway Biopharmaceuticals Co?

The current dividend yield of Caliway Biopharmaceuticals Co is .

When does Caliway Biopharmaceuticals Co pay dividends?

Caliway Biopharmaceuticals Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Caliway Biopharmaceuticals Co?

Caliway Biopharmaceuticals Co paid dividends every year for the past 0 years.

What is the dividend of Caliway Biopharmaceuticals Co?

For the upcoming 12 months, dividends amounting to 0 TWD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Caliway Biopharmaceuticals Co located?

Caliway Biopharmaceuticals Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Caliway Biopharmaceuticals Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Caliway Biopharmaceuticals Co from 10/1/2024 amounting to 0 TWD, you needed to have the stock in your portfolio before the ex-date on 10/1/2024.

When did Caliway Biopharmaceuticals Co pay the last dividend?

The last dividend was paid out on 10/1/2024.

What was the dividend of Caliway Biopharmaceuticals Co in the year 2023?

In the year 2023, Caliway Biopharmaceuticals Co distributed 0 TWD as dividends.

In which currency does Caliway Biopharmaceuticals Co pay out the dividend?

The dividends of Caliway Biopharmaceuticals Co are distributed in TWD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Caliway Biopharmaceuticals Co

Our stock analysis for Caliway Biopharmaceuticals Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Caliway Biopharmaceuticals Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.